Discover and read the best of Twitter Threads about #CancerScreening
Most recents (9)
There have been some acquisitions in #CancerDiagnostics and #CancerScreening recently, some of which signify a trend towards consolidation that is worth describing:
$A Agilent is moving towards some more vertical integration in Cancer Dx and Cancer screening
$A Agilent is moving towards some more vertical integration in Cancer Dx and Cancer screening
by recently acquiring both announcing a partnership with Akoya Bio and announcing the acquisition of Avida Biomed. 
Some may ask: isn’t $A Agilent too small to go into this field? Would they be able to compete against $ILMN Illumina/GrailBio or $GH Guardant Health or $EXAS Exact Sciences?
An article describing the "45 is the new 50" change in guidelines in the US for #ColorectalCancer #Screening. Slightly biased towards $EXAS Exact Sciences Cologuard. ache.org/blog/2022/upda…
$EXAS Exact Sciences is one of the companies I track, in many ways a pioneer in the #LiquidBiopsy #CancerScreening field although with a low-tech method compared to other players in this field such as $ILMN Illumina (via @GrailBio), and what other companies are planning ...
@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 2/ 📸 Faculty disclosures & CME certification ℹ 👇
#CME certificate 🏅 → ℹ️ bit.ly/3GOowNG
#CME certificate 🏅 → ℹ️ bit.ly/3GOowNG
@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 3/ 👌let's 🚴
In addition to 💉, pts w #IBD should undergo regular #PreventiveHealth #HCM:
📌Cancer Screening 🦀
📌Bone Health assessment 🦴
📌Mental Health 🥺
📌Treatment specific Testing 💉💊
📌Nutrition
📌Smoking cessation 🚬
#ICYMI vaccines #MNIBDTweetorial 📎 @🔚 of 🧵
In addition to 💉, pts w #IBD should undergo regular #PreventiveHealth #HCM:
📌Cancer Screening 🦀
📌Bone Health assessment 🦴
📌Mental Health 🥺
📌Treatment specific Testing 💉💊
📌Nutrition
📌Smoking cessation 🚬
#ICYMI vaccines #MNIBDTweetorial 📎 @🔚 of 🧵
@MondayNightIBD @DCharabaty @JanssenUS @pfizer @TakedaPharma 4/ 🧩Who is IS? #IBD pts on or had within last 3 months:
🚩 Prednisone > 20mg/day >2wks
🚩 AZA >2.5 mg/kg/day
🚩 6MP >1.5 mg/kg/day
🚩 MTX >0.4 mg/kg/week
🚩 Cyclosporine
🚩 Tacrolimus
🚩 Tofacitinib, ozanimod
🚩 TNFi, UST
Also:
🚩 Significant protein-calorie malnutrition
🚩 Prednisone > 20mg/day >2wks
🚩 AZA >2.5 mg/kg/day
🚩 6MP >1.5 mg/kg/day
🚩 MTX >0.4 mg/kg/week
🚩 Cyclosporine
🚩 Tacrolimus
🚩 Tofacitinib, ozanimod
🚩 TNFi, UST
Also:
🚩 Significant protein-calorie malnutrition
In #biotech #stocks, more market jitters at NASDAQ opening, all biotech stocks down except for $ONT.L Oxford @nanopore and $NEO NeoGenomics
$ONT.L Oxford @nanopore floated on Wednesday, today still on a steady uphill. Trades in London stock exchange, so off by 4-5 hours US East time.
$NEO NeoGenomics has been on a tear in the last few days. A company growing both organically and by acquisition, aggressively positioning itself in the #LiquidBiopsy #CancerScreening segment.
(1) Possible buyout of #ARM by #NVIDIA does have an effect on the #Bioinformatics field: many applications now are deployable on CPU/GPUs with #ARM and/or #NVIDIA chips on them. Some recent examples are:
(a) the Oxford @nanopore MinION Mk1c device, which originally was specced at Jetson TX2 ARM+Pascal GPU accelerators (ARM processor 6 cores, 256 Core GPU), 8 GB RAM (may have changed since then.
Epigenomic biomarkers are becoming more established for #LiquidBiopsy and #CancerScreening, and we have seen the big players positioning themselves in this #epigenomics race recently.
Catching signs of #cancer early is crucially important to the disease management and survival rates, so the question is: how can we find out if there is something wrong going on early enough, ideally in a low-cost assay that can be performed regularly on healthy individuals?
@sbarnettARK Epigenomic biomarkers are becoming more established for #LiquidBiopsy and #CancerScreening, and we have seen the big players positioning themselves in this #epigenomics race recently.
@sbarnettARK Catching signs of #cancer early is crucially important to the disease management and survival rates, so the question is: how can we find out if there is something wrong going on early enough?
@sbarnettARK The first generation of high-throughput technologies was predicated on finding mutated (tumor) DNA in the individual's body (somatic), different from their (normal) DNA. Tumor/Normal (T/N) comparisons of the individual's samples, biopsies or ctDNA will indicate if there
1/13 Really interesting read Rory. Thx for sharing. I agree, its v difficult to remain clear headed when theres so much data & it can all be interpreted in different ways. Prof. @AndrewEwing11 is unhappy with #Sweden's strategy and has been openly critical - he's entitled to that
2/13 I think that data is being represented in a way that suits the narrative.I added extra columns:"since Aug 7" & "since Sept 7".I used Oct 14 as end point (date of publication).I also highlighted Netherlands in red as it was best performing in the table and good for comparison
3/13 In Sweden from Aug to Oct there was a 3% increase in cumulative deaths per 100k and from Sept to Oct there was a 1% increase. Meanwhile, Netherlands (best of the worst) had 8% & 6% increases in cumulative deaths per 100k respectively.
October is Breast Cancer Awareness month.
I wish to update everyone on the role we play in early detection and treatment for women affected by this terrible disease.
#breastcancer #October #breastcancerawareness #Pune #dentist #cancerscreening
I wish to update everyone on the role we play in early detection and treatment for women affected by this terrible disease.
#breastcancer #October #breastcancerawareness #Pune #dentist #cancerscreening
As part of my training at the University of Pennsylvania, we were taught the role of regular Oral Cancer Screening to be carried out at each visit.
The mandible is the most common site for metastasis aka secondary spread of Breast Cancer.
The mandible is the most common site for metastasis aka secondary spread of Breast Cancer.
As such we contribute both towards primary diagnosis and ruling out recurrence. A simple panoramic xray is generally sufficient in most cases.
If a patient is to undergo Chemotherapy, it becomes very important to eliminate all potential sources of infection.
If a patient is to undergo Chemotherapy, it becomes very important to eliminate all potential sources of infection.
